The Paradigm RT (Real Time) series adds the ability to receive data from a mated continuous blood-glucose monitor.
The Minimed Paradigm REAL-Time and Continuous Glucose Monitoring (CGM) system, which received FDA clearance in 2006, uses tubing and a reservoir with rapid-acting insulin.
[4] The Paradigm system consists of two basic parts: an insulin pump and an optional glucose sensor CGM worn for up to three days.
The disposable sensor is subcutaneously-placed to make glucose measurements[5] in interstitial fluid every five minutes and transmit the reading via low power radio frequency (ISM band) to the pump for realtime display.
Competitive devices include Deltec Cozmo, Animas Ping, Tandem Diabetes Care, Inc., Insulet OmniPod, Accu-chek Spirit Combo, and Sooil DiabecareIIS.
[18] While the slow-responding dynamics in the physiology of glucose regulation is not beyond the mathematics of PID controllers, 50 years of patient-perspective "advancement" says it is beyond the corporate, congressional, and lobbying leaders.